Is Crescent Biopharma, Inc. overvalued?

Crescent Biopharma, Inc. (CBIO) — key valuation metrics and fundamentals.

No verdict

Price

$17.14

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$636.6M

Dividend yield

0.0%

Return on equity

-97.8%

Sector

Healthcare

Fair value compares CBIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks